Methicillin-resistant staphylococcus aureus colonization, its relationship to nosocomial infection, and efficacy of control methods

Anesthesiology

Volumn 113, Issue 6, 2010, Pages 1453-1459

  Butterly, Arielle ^a   Schmidt, Ulrich ^a   Wiener Kronish, Jeanine ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFOTAXIME; CHLORHEXIDINE; COLISTIN; METICILLIN; POVIDONE IODINE; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; PSEUDOMONAS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 78650175613     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181fcf671     Document Type: Note

References (48)

1. Paster BJ, Olsen I, Aas JA, Dewhirst FE: The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000 2006; 42:80-7
2. Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, Cardo DM: Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007; 122:160-6
3. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators: International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302:2323-9
4. Vincent JL: Nosocomial infections in adult intensive-care units. Lancet 2003; 361:2068-77
5. NNIS System: National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003; 31:481-98
6. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK, Active Bacterial Core surveillance (ABCs) MRSA Investigators: Invasive methicillin-resistant Staphy-lococcus aureus infections in the United States. JAMA 2007; 298:1763-71
7. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, Jensen BJ, Killgore G, Tenover FC, Kuehnert MJ: Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008; 197:1226-34
8. Klein E, Smith DL, Laxminarayan R: Hospitalizations and deaths caused by methicillin-resistant Staphylococcus au-reus, United States, 1999-2005. Emerg Infect Dis 2007; 13:1840-6
9. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y: The impact of methicillin resistance in Staph-ylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26:166-74
10. Bancroft EA: Antimicrobial resistance: It's not just for hospitals. JAMA 2007; 298:1803-4
11. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bron-stein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS: Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003; 36: 592-8
12. Robicsek A, Beaumont JL, Paule SM, Hacek DM, Thomson RB Jr, Kaul KL, King P, Peterson LR: Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008; 148:409-18
13. Wang FD, Chen YY, Chen TL, Liu CY: Risk factors and mortality in patients with nosocomial Staphylococcus au-reus bacteremia. Am J Infect Control 2008; 36:118-22
14. Romero-Vivas J, Rubio M, Fernandez C, Picazo JJ: Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995; 21: 1417-23
15. Beyersmann J, Gastmeier P, Grundmann H, Bärwolff S, Geffers C, Behnke M, Rüden H, Schumacher M: Transmission-associated nosocomial infections: Prolongation of intensive care unit stay and risk factor analysis using multi-state models. Am J Infect Control 2008; 36:98-103
16. Grundmann H, B̈arwolff S, Tami A, Behnke M, Schwab F, Geffers C, Halle E, Göbel UB, Schiller R, Jonas D, Klare I, Weist K, Witte W, Beck-Beilecke K, Schumacher M, Rüden H, Gastmeier P: How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med 2005; 33:946-51
17. Weist K, Pollege K, Schulz I, Rüden H, Gastmeier P: How many nosocomial infections are associated with cross-transmission? A prospective cohort study in a surgical intensive care unit. Infect Control Hosp Epidemiol 2002; 23:127-32
18. Safdar N, Bradley EA: The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 2008; 121:310-5
19. Creech CB 2nd, Talbot TR, Schaffner W: Community-associated methicillin-resistant Staphylococcus aureus: The way to the wound is through the nose. J Infect Dis 2006; 193:169-71
20. Perl TM, Golub JE: New approaches to reduce Staphylo-coccus aureus nosocomial infection rates: Treating S. au-reus nasal carriage. Ann Pharmacother 1998; 32:S7-16
21. Mest DR, Wong DH, Shimoda KJ, Mulligan ME, Wilson SE: Nasal colonization with methicillin-resistant Staphylococ-cus aureus on admission to the surgical intensive care unit increases the risk of infection. Anesth Analg 1994; 78: 644-50
22. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR: Methicillin-resistant Staphylococcus aureus (MRSA) na-res colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004; 39:776-82
23. Kluytmans JA, Mouton JW, Ijzerman EP, Vandenbroucke-Grauls CM, Maat AW, Wagenvoort JH, Verbrugh HA: Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995; 171:216-9
24. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR: Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20:250-78
25. Fierobe L, Decré D, Mùller C, Lucet JC, Marmuse JP, Mantz J, Desmonts JM: Methicillin-resistant Staphylococcus au-reus as a causative agent of postoperative intra-abdominal infection: Relation to nasal colonization. Clin Infect Dis 1999; 29:1231-8
26. Keene A, Lemos-Filho L, Levi M, Gomez-Marquez J, Yunen J, Said H, Lowy FD: The use of a critical care consult team to identify risk for methicillin-resistant Staphylococcus au-reus infection and the potential for early intervention: A pilot study. Crit Care Med 2010; 38:109-13
27. Von Eiff C, Becker K, Machka K, Stammer H, Peters G: Nasal carriage as a source of Staphylococcus aureus bacte-remia. Study Group. N Engl J Med 2001; 344:11-6
28. Diekema DJ, Climo M: Preventing MRSA infections: Finding it is not enough. JAMA 2008; 299:1190-2
29. Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, Olmsted RN, Bonten M, Lundstrom T, Climo MW, Roghmann MC, Murphy CL, Karchmer TB, Society for Healthcare Epidemiology of America, Association of Professionals in Infection Control and Epidemiology: Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol 2007; 28:249-60
30. Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Ger-vaz P, Bandiera-Clerc C, Renzi G, Vernaz N, Sax H, Pittet D: Universal screening for methicillin-resistant Staphylococ-cus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008; 299:1149-57
31. Harbarth S, Masuet-Aumatell C, Schrenzel J, Francois P, Akakpo C, Renzi G, Pugin J, Ricou B, Pittet D: Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococ-cus aureus in critical care: An interventional cohort study. Crit Care 2006; 10:R25
32. Robicsek A, Beaumont JL, Peterson LR: Duration of colonization with methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2009; 48:910-3
33. Keshtgar MR, Khalili A, Coen PG, Carder C, Macrae B, Jeanes A, Folan P, Baker D, Wren M, Wilson AP: Impact of rapid molecular screening for meticillin-resistant Staphylo-coccus aureus in surgical wards. Br J Surg 2008; 95:381-6
34. Silvestri L, Monti Bragadin C, Milanese M, Gregori D, Consales C, Gullo A, van Saene HK: Are most ICU infections really nosocomial? A prospective observational cohort study in mechanically ventilated patients. J Hosp Infect 1999; 42:125-33
35. De Jonge E: Effects of selective decontamination of diges-tive tract on mortality and antibiotic resistance in the intensive-care unit. Curr Opin Crit Care 2005; 11:144-9
36. Bonten MJ: Selective digestive tract decontamination-will it prevent infection with multidrug-resistant Gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomy-cin-resistant enterococci are endemic? Clin Infect Dis 2006; 43(suppl 2):S70-4
37. De Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, Van Der Werf TS, Van Der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJ, Bernards AT, Kuijper EJ, Joore JC, Leverstein-van Hall MA, Bindels AJ, Jansz AR, Wesselink RM, de Jongh BM, Dennesen PJ, van Asselt GJ, te Velde LF, Frenay IH, Kaasjager K, Bosch FH, van Iterson M, Thijsen SF, Kluge GH, Pauw W, de Vries JW, Kaan JA, Arends JP, Aarts LP, Sturm PD, Harinck HI, Voss A, Uij-tendaal EV, Blok HE, Thieme Groen ES, Pouw ME, Kalkman CJ, Bonten MJ: Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009; 360:20-31
38. D'Amico R, Pifferi S, Leonetti C, Torri V, Tinazzi A, Liberati A: Effectiveness of antibiotic prophylaxis in critically ill adult patients: Systematic review of randomised controlled trials. BMJ 1998; 316:1275-85
39. Liberati A, D'Amico R, Pifferi, Torri V, Brazzi L: Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev 2004; (1):CD000022
40. American Thoracic Society, Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
41. Oostdijk EA, De Smet AM, Blok HE, Thieme Groen ES, Van Asselt GJ, Benus RF, Bernards SA, Frénay IH, Jansz AR, de Jongh BM, Kaan JA, Leverstein-van Hall MA, Mascini EM, Pauw W, Sturm PD, Thijsen SF, Kluytmans JA, Bonten MJ: Ecological effects of selective decontamination on resistant Gram-negative bacterial colonization. Am J Respir Crit Care Med 2010; 181:452-7
42. Chan EY, Ruest A, Meade MO, Cook DJ: Oral decontamination for prevention of pneumonia in mechanically ventilated adults: Systematic review and meta-analysis. BMJ 2007; 334:889
43. Sona CS, Zack JE, Schallom ME, McSweeney M, McMullen K, Thomas J, Coopersmith CM, Boyle WA, Buchman TG, Mazuski JE, Schuerer DJ: The impact of a simple, low-cost oral care protocol on ventilator-associated pneumonia rates in a surgical intensive care unit. J Intensive Care Med 2009; 24:54-62
44. Segers P, Speekenbrink RG, Ubbink DT, van Ogtrop ML, de Mol BA: Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oro-pharynx with chlorhexidine gluconate: A randomized controlled trial. JAMA 2006; 296:2460-6
45. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vanden-broucke-Grauls CM, Roosendaal R, Troelstra A, Box AT, Voss A, van der Tweel I, van Belkum A, Verbrugh HA, Vos MC: Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362:9-17
46. Climo MW, Sepkowitz KA, Zuccotti G, Fraser VJ, Warren DK, Perl TM, Speck K, Jernigan JA, Robles JR, Wong ES: The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: Results of a quasi-experimental multicenter trial. Crit Care Med 2009; 37:1858-65
47. Finkelstein R, Rabino G, Mashiah T, Bar-El Y, Adler Z, Kertzman V, Cohen O, Milo S: Vancomycin versus cefazo-lin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg 2002; 123:326-32
48. Tacconelli E, Cataldo MA, Albanese A, Tumbarello M, Ar-duini E, Spanu T, Fadda G, Anile C, Maira G, Federico G, Cauda R: Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2008; 69:337-44